Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jun 29:11:750.
doi: 10.3332/ecancer.2017.750. eCollection 2017.

Intraoperative radiotherapy: review of techniques and results

Affiliations
Review

Intraoperative radiotherapy: review of techniques and results

Avinash Pilar et al. Ecancermedicalscience. .

Abstract

Intraoperative radiotherapy (IORT) is a technique that involves precise delivery of a large dose of ionising radiation to the tumour or tumour bed during surgery. Direct visualisation of the tumour bed and ability to space out the normal tissues from the tumour bed allows maximisation of the dose to the tumour while minimising the dose to normal tissues. This results in an improved therapeutic ratio with IORT. Although it was introduced in the 1960s, it has seen a resurgence of popularity with the introduction of self-shielding mobile linear accelerators and low-kV IORT devices, which by eliminating the logistical issues of transport of the patient during surgery for radiotherapy or building a shielded operating room, has enabled its wider use in the community. Electrons, low-kV X-rays and HDR brachytherapy are all different methods of IORT in current clinical use. Each method has its own unique set of advantages and disadvantages, its own set of indications where one may be better suited than the other, and each requires a specific kind of expertise. IORT has demonstrated its efficacy in a wide variety of intra-abdominal tumours, recurrent colorectal cancers, recurrent gynaecological cancers, and soft-tissue tumours. Recently, it has emerged as an attractive treatment option for selected, early-stage breast cancer, owing to the ability to complete the entire course of radiotherapy during surgery. IORT has been used in a multitude of roles across these sites, for dose escalation (retroperitoneal sarcoma), EBRT dose de-escalation (paediatric tumours), as sole radiation modality (early breast cancers) and as a re-irradiation modality (recurrent rectal and gynaecological cancers). This article aims to provide a review of the rationale, techniques, and outcomes for IORT across different sites relevant to current clinical practice.

Keywords: IORT; complications; indications; outcomes; techniques.

PubMed Disclaimer

References

    1. Abe M, Shibamoto Y, Ono K, et al. Intraoperative radiation therapy for carcinoma of the stomach and pancreas. Front Radiat Ther Oncol. 1991;25:258–69. doi: 10.1159/000429597. - DOI - PubMed
    1. Abe M, Takahashi M. Intraoperative radiotherapy: the Japanese experience. Int J Radiat Oncol Biol Phys. 1981;7(7):863–8. doi: 10.1016/0360-3016(81)90001-8. - DOI - PubMed
    1. Abe MFM, Yaniano K, et al. Intraoperative irradiation in abdominal and cerebral tumours. Acta Radiol. 1971;10:408–16. - PubMed
    1. Intraoperative radiation therapy. Proceedings of the third international symposium on intraoperative radiation therapy. In: Abe M, Takahashi M, editors. 1991.
    1. Goldson A. Past, present and prospects of intraoperative radiotherapy (IOR) Semin Oncol. 1981 - PubMed

LinkOut - more resources